What the Research Says About Taking a Daily Multivitamin
A deep review of 10+ clinical studies on daily multivitamin use. Study tables, balanced conclusions, and what the evidence means for your individual decision.
The question of whether a daily multivitamin improves health has generated more than 400 randomized controlled trials, dozens of meta-analyses, and a seemingly endless cycle of contradictory headlines. Some researchers call multivitamins essential insurance. Others call them expensive placebos. The truth, as usual, lives in the data — and the data tells a more interesting story than either camp acknowledges.
This article reviews the most influential studies on daily multivitamin use, organized chronologically, with study design details and key findings summarized for clarity. The goal is not to tell you what to do, but to give you the evidence to decide for yourself.
The Master Study Table
| Authors / Study Name | Year | Sample Size | Population | Duration | Key Finding |
|---|---|---|---|---|---|
| Physicians' Health Study II (PHS II) — Cancer | 2012 | 14,641 | Male physicians, age 50+ | 11.2 years | 8% reduction in total cancer incidence (HR 0.92, 95% CI 0.86–0.998) — modest, borderline significant |
| Physicians' Health Study II (PHS II) — CVD | 2012 | 14,641 | Male physicians, age 50+ | 11.2 years | No significant reduction in major cardiovascular events (HR 0.94, 95% CI 0.87–1.01) |
| Iowa Women's Health Study | 2011 | 38,772 | Older women, age 55–69 | 19 years | No mortality benefit from multivitamins; iron supplementation associated with slightly increased mortality risk |
| USPSTF Systematic Review | 2022 | Meta-analysis of 84 studies | General adult population | Varies | Insufficient evidence to recommend multivitamins for prevention of CVD, cancer, or mortality |
| COSMOS-Mind | 2022 | 2,262 | Adults 65+ | 3 years | Daily multivitamin significantly slowed cognitive decline (equivalent to ~1.8 years of preserved function) |
| COSMOS-Web | 2023 | 3,562 | Adults 60+ | 1 year | Multivitamin improved immediate recall (effect size: 0.71 standard units) and delayed recall vs placebo |
| Baker et al., Age and Ageing | 2023 | 1,845 | Adults 70+ | 2 years | Improved immune response markers and 14% reduction in self-reported infections |
| Blumberg et al., Nutrients | 2017 | Meta-analysis of 21 RCTs | Mixed | Varies | Multivitamin use reduced the risk of micronutrient inadequacy by 58–72% depending on the nutrient |
| Thomas-Valdés et al., AJCN | 2017 | Meta-analysis of 17 RCTs | Pregnant women | Varies | Multivitamins reduced risk of low birth weight (RR 0.88) and preterm birth (RR 0.87) |
| Ward, Nutrients | 2014 | NHANES analysis, 10,698 | US adults | Cross-sectional | Multivitamin users had significantly higher intakes and serum levels of vitamins A, B6, B12, C, D, E, folate, iron, and zinc |
| Li et al., Frontiers in Nutrition | 2024 | Meta-analysis of 28 RCTs | General adults | Varies | Multivitamin supplementation significantly reduced CRP (inflammatory marker) in subgroups with baseline deficiency |
| Macpherson et al., Human Psychopharmacology | 2012 | 215 | Healthy working men, 30–55 | 33 days | Multivitamin improved ratings of stress, mental health, vigor, and cognitive performance under multi-tasking |
Study-by-Study Analysis
Physicians' Health Study II (2012): The Landmark Trial
The Physicians' Health Study II remains the largest and longest randomized, double-blind, placebo-controlled trial of a daily multivitamin ever conducted. It followed 14,641 male physicians aged 50 and older for more than 11 years. The trial used Centrum Silver, a widely available commercial multivitamin.
Cancer findings: The multivitamin group had an 8% lower incidence of total cancer compared to placebo. While statistically significant (barely — the confidence interval nearly crossed 1.0), the effect was modest. Notably, the benefit was driven primarily by cancers other than prostate, and the reduction was more pronounced in men who had a prior history of cancer.
Cardiovascular findings: There was no statistically significant reduction in major cardiovascular events, including heart attack, stroke, or cardiovascular death. The hazard ratio of 0.94 suggested a possible small benefit, but the confidence interval included 1.0, meaning the result could be due to chance.
Interpretation: The PHS II provides weak evidence that a daily multivitamin may modestly reduce cancer risk in older men, but does not support multivitamins for cardiovascular prevention. The study population — physicians with above-average health behaviors — may not generalize to the broader population.
COSMOS Trials (2022–2023): The Cognitive Breakthrough
The COSMOS (COcoa Supplement and Multivitamin Outcomes Study) trials represent the most significant recent evidence in favor of daily multivitamin use, specifically for cognitive health in older adults.
COSMOS-Mind (2022): This ancillary study of the COSMOS trial assessed cognitive function in 2,262 adults aged 65 and older using validated telephone-based cognitive assessments at baseline and annually for three years. The multivitamin group (Centrum Silver) showed significantly less cognitive decline than the placebo group. The effect was equivalent to approximately 1.8 years of preserved cognitive function — a meaningful clinical difference. Participants with cardiovascular disease showed the greatest benefit.
COSMOS-Web (2023): This internet-based ancillary study tested 3,562 adults aged 60 and older using online cognitive assessments. The multivitamin group showed significant improvements in immediate memory recall. The effect was reproducible and consistent across subgroup analyses.
Interpretation: The COSMOS data is the strongest evidence to date that daily multivitamin use may protect cognitive function in aging. The results have been described as "cautiously exciting" by independent reviewers. However, the mechanism is unclear — it could be driven by a specific nutrient (such as B12 or folate) rather than the broad-spectrum formulation.
USPSTF Systematic Review (2022): The Policy Position
The US Preventive Services Task Force reviewed 84 studies and concluded there is insufficient evidence to recommend multivitamin supplementation for the prevention of cardiovascular disease, cancer, or mortality in the general adult population. This review informed the widely cited headline "multivitamins are not recommended."
Important nuances often missed in media coverage:
"Insufficient evidence" is not the same as "evidence of no benefit." The USPSTF found that evidence was inconsistent and of moderate certainty, not that multivitamins were proven useless. The review explicitly excluded cognitive outcomes (the COSMOS data was published around the same time), pregnancy-related outcomes, and populations with known deficiencies. The recommendation applies to the general, non-pregnant adult population for the specific outcomes of CVD, cancer, and death — not for other health endpoints.
Iowa Women's Health Study (2011): The Cautionary Data
This observational study followed 38,772 older women over 19 years and found no mortality benefit from multivitamin use. More controversially, it found that supplemental iron was associated with a small but significant increase in mortality risk.
Limitations: This was an observational study, not a randomized trial. Women who took supplements may have differed from non-users in ways that confounded the results. The iron finding may reflect reverse causation — women with health conditions associated with anemia may have been more likely to take iron supplements and more likely to die. Observational studies cannot establish causation.
Blumberg et al. (2017): The Nutrient Gap Evidence
This meta-analysis of 21 randomized controlled trials examined whether multivitamins actually improve micronutrient status. The answer was unambiguous: multivitamin users had 58–72% lower rates of nutrient inadequacy compared to non-users, with the largest improvements in vitamins D, E, and K — nutrients that are difficult to obtain in adequate amounts from typical diets.
This study does not address disease prevention, but it confirms the fundamental mechanism by which multivitamins should work: they fill measurable nutrient gaps.
Li et al. (2024): The Inflammation Connection
A recent meta-analysis of 28 randomized controlled trials examined the effect of multivitamins on C-reactive protein (CRP), a marker of systemic inflammation linked to cardiovascular disease, diabetes, and many chronic conditions. In the overall analysis, the effect was small and not significant. However, in subgroup analysis of participants with baseline nutrient deficiencies, multivitamins significantly reduced CRP levels. This suggests the anti-inflammatory benefit of multivitamins is real but conditional — it depends on whether the individual has deficiencies that supplementation corrects.
The Pattern in the Data
Across all studies reviewed, a consistent pattern emerges:
- For major disease endpoints (heart attack, cancer, death) in well-nourished populations: multivitamins show little or no benefit.
- For nutrient status and biomarkers in populations with gaps: multivitamins consistently improve serum levels, reduce inadequacy rates, and normalize biomarkers.
- For cognitive function in older adults: multivitamins show promising and replicable benefit.
- For pregnancy outcomes: multivitamins reduce risk of complications.
- For athletes and people in caloric deficit: multivitamins maintain nutrient status during periods of restricted intake.
The conclusion is not that multivitamins are universally good or universally useless. It is that benefit depends on individual nutritional status. If you have gaps, supplementation fills them. If you do not, it does not add much.
Why Individual Nutritional Status Is the Key Variable
The most important variable in the multivitamin debate — individual nutritional status — is the one most studies fail to adequately control for. Trials that enroll well-nourished populations and find no benefit are not disproving the value of supplementation; they are confirming that people who already have adequate nutrition do not need more.
The practical implication is straightforward: before deciding whether to take a daily multivitamin, you need to know your own nutritional status. This is where tools like the Nutrola app become critical — by tracking your actual food intake, you can identify which specific nutrients your diet provides in adequate amounts and which ones fall consistently short.
How Nutrola Daily Essentials Fits Into the Evidence
Nutrola Daily Essentials is a daily drink combining vitamins, minerals, and botanicals at clinically studied doses. It addresses the primary criticism of generic multivitamins — underdosing and poor bioavailability — by using bioavailable nutrient forms and publishing full ingredient amounts transparently (no proprietary blends).
The product is lab tested by independent third-party laboratories, EU certified, and made with 100% natural ingredients. No artificial fillers, colors, or sweeteners. Sustainable packaging. It has earned 4.8 stars across 316,000+ verified reviews.
Paired with the Nutrola app, users can see their personal nutrient data alongside their supplementation — understanding exactly which gaps Daily Essentials fills in their specific diet, rather than taking a supplement blindly and hoping for the best.
A Balanced Conclusion
The research on daily multivitamins does not support blanket recommendations for or against supplementation. What it supports is a personalized approach:
- If you are over 65 and concerned about cognitive decline, the COSMOS data provides meaningful evidence in favor of daily multivitamin use.
- If you are pregnant or planning pregnancy, multivitamins (specifically prenatal formulations) are unambiguously recommended.
- If you eat a restrictive diet, are in a caloric deficit, or have absorption issues, multivitamins fill documented gaps.
- If you eat a varied, high-calorie, whole food diet with no risk factors for deficiency, multivitamins are unlikely to prevent major disease — but they are also unlikely to cause harm.
The most rational approach in 2026 is to use data, not assumptions. Track your nutrition. Identify your gaps. Supplement where the evidence supports it.
Frequently Asked Questions
What is the strongest evidence for daily multivitamin use?
The COSMOS-Mind trial (2022) provides the strongest recent evidence, showing that a daily multivitamin significantly slowed cognitive decline in adults over 65 — equivalent to approximately 1.8 years of preserved cognitive function over three years. For pregnancy, meta-analyses consistently show reduced risk of low birth weight and preterm birth with prenatal multivitamins. For micronutrient status, multiple studies confirm that multivitamins reduce inadequacy rates by 58–72%.
What is the strongest evidence against daily multivitamin use?
The USPSTF 2022 systematic review of 84 studies found insufficient evidence that multivitamins prevent cardiovascular disease, cancer, or death in the general adult population. The Iowa Women's Health Study (2011) found no mortality benefit over 19 years of follow-up. These findings are most applicable to well-nourished adults without specific risk factors for deficiency.
Do multivitamins actually get absorbed by the body?
Yes. Multiple studies measuring serum nutrient levels before and after multivitamin supplementation show significant increases in blood concentrations of vitamins and minerals. The Ward (2014) NHANES analysis found that multivitamin users had significantly higher serum levels of vitamins A, B6, B12, C, D, E, folate, iron, and zinc. Absorption varies by nutrient form — for example, methylfolate is absorbed more effectively than folic acid, and vitamin D3 is more bioavailable than D2. Nutrola Daily Essentials uses the most bioavailable forms of each nutrient.
How long do I need to take a multivitamin to see benefits?
Blood nutrient levels typically improve within 4–8 weeks of consistent daily supplementation. Cognitive benefits in the COSMOS trial were measured at 1 year and 3 years. Subjective benefits like improved energy and reduced fatigue are commonly reported within 6–8 weeks, particularly by individuals who had baseline deficiencies. There is no credible evidence for immediate or same-day effects from a multivitamin.
Should I take a multivitamin or just eat better?
Both, ideally — but the answer depends on your starting point. If you are currently eating a poor diet, improving your food quality should be the priority, as whole foods provide fiber, phytonutrients, and health benefits that no supplement replicates. However, even well-intentioned diets often fall short on specific nutrients (vitamin D, magnesium, and vitamin E are common gaps). The Nutrola app helps you track your actual intake and identify where food alone is insufficient — making the decision data-driven rather than based on guesswork.
Ready to Transform Your Nutrition Tracking?
Join thousands who have transformed their health journey with Nutrola!